What is Alto Neuroscience Inc. Annual Net Profit?

Alto Neuroscience Inc. Annual Net Profit fell 69.21% in the last year to $61.43 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

What is Alto Neuroscience Inc. Price to Earning Ratio?

Alto Neuroscience Inc. Price to Earning Ratio is -1.02, which is negative.

What is Alto Neuroscience Inc. Stock Price?

Alto Neuroscience Inc. Stock Price fell 82.18% and underperformed its sector by 95.45% in the past year.

What is Alto Neuroscience Inc. Quarterly Net profit?

Alto Neuroscience Inc. Quarterly Net profit fell 35.52% YoY to $15.2 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

What is Alto Neuroscience Inc. Debt to Equity Ratio?

Alto Neuroscience Inc. Debt to Equity Ratio of 0.11 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Alto Neuroscience Inc. Return on Equity(ROE)?

Alto Neuroscience Inc. Return on Equity(ROE) for the last financial year was -153.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Alto Neuroscience Inc. Mutual Fund Holding?

Alto Neuroscience Inc. Mutual Fund Holding decreased by 0.28% in the last quarter to 27.28.

What is Alto Neuroscience Inc. Interest Coverage Ratio?

Alto Neuroscience Inc. Interest Coverage Ratio is -43.68, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Alto Neuroscience Inc. Institutional Holding?

Alto Neuroscience Inc. Institutional Holding increased by 0.01% in the last quarter to 81.84.

How is the Alto Neuroscience Inc. today?

The Alto Neuroscience Inc. today is trading in the down by -0.43% at 2.31.

How has Alto Neuroscience Inc. performed historically?

The Alto Neuroscience Inc. is currently trading down -0.43% on an intraday basis in the past week the index rose 11.06%. The index has been down -51.16% in the past quarter and fell -82.18% in the past year. You can view this in the overview section.

Alto Neuroscience Inc. XNYS: ANRO

Alto Neuroscience Inc. Live Share Price Today, Share Analysis and Chart

Name: Alto Neuroscience Inc.: Is Infosys Ltd. worth buying?
Item: Alto Neuroscience Inc.
Rating: 0.97408325
Author: Trendlyne DVM scores

Download real time

2.31 -0.01 (-0.43%)

86.84% Fall from 52W High

31,183 XNYS Volume

XNYS 22 Apr, 2025 12:29 PM (EDT)

Board Meeting

The next board meeting for Alto Neuroscience Inc. is on 30 Apr 2025 for the purpose of Alto Neuroscience Inc Annual General Meeting for 2024 See details

Alto Neuroscience Inc. Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	62.5
PE TTM Negative PE TTM Unavailable in chosen country	-1
Price to Book Low in industry Unavailable in chosen country	0.4
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	81.8
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-35.5
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-69.2
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-47.5
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-154
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-46.5

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

14.8 / 100

Technically Bearish

24.1 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Alto Neuroscience Inc. Stock Price Analysis

Day Price Range -0.4% 1 Day return Unavailable in chosen country	2.3 (LTP) 2.22.4 LowHigh
Week Price Range 11.1% 1 Week return Unavailable in chosen country	2.3 (LTP) 22.4 LowHigh
Month Price Range -12.8% 1 Month return Unavailable in chosen country	2.3 (LTP) 1.62.8 LowHigh
52 Week Price Range -82.2% 1 Year return Unavailable in chosen country	2.3 (LTP) 1.617.6 LowHigh

View full Share Price History

Alto Neuroscience Inc. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Alto Neuroscience Inc. Stock Analysis

Alto Neuroscience Inc. stock analysis with key metrics, changes, and trends.

Alto Neuroscience Inc. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$61.43 M	69.21%	negative	Annual Net Profit fell 69.21% in the last year to $61.43 M. Its sector's average net profit growth for the last fiscal year was -17.35%.
Price to Earning Ratio	-1.02	-	negative	Price to Earning Ratio is -1.02, which is negative.
Stock Price	$2.31	-82.18%	negative	Stock Price fell 82.18% and underperformed its sector by 95.45% in the past year.
Quarterly Net profit	$15.2 M	35.52%	negative	Quarterly Net profit fell 35.52% YoY to $15.2 M. Its sector's average net profit growth YoY for the quarter was -51.46%.
Debt to Equity Ratio	0.11	-	positive	Debt to Equity Ratio of 0.11 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-153.99 %	-153.99%	negative	Return on Equity(ROE) for the last financial year was -153.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	27.28 %	-0.28%	negative	Mutual Fund Holding decreased by 0.28% in the last quarter to 27.28.
Interest Coverage Ratio	-43.68	-	negative	Interest Coverage Ratio is -43.68, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	81.84 %	0.01%	positive	Institutional Holding increased by 0.01% in the last quarter to 81.84.

VIEW LESS

Loading data..

Alto Neuroscience Inc. - Company Profile

What does Alto Neuroscience Inc. do?

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

383.89 K

2024

Gross Remuneration

Year

Alto Neuroscience Inc. Live Share Price Today, Share Analysis and Chart

86.84% Fall from 52W High

Alto Neuroscience Inc. Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Alto Neuroscience Inc. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Alto Neuroscience Inc. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Alto Neuroscience Inc. Stock Analysis

Alto Neuroscience Inc. stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 69.21% in the last year to $61.43 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

Price to Earning Ratio is -1.02, which is negative.

Stock Price fell 82.18% and underperformed its sector by 95.45% in the past year.

Quarterly Net profit fell 35.52% YoY to $15.2 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

Debt to Equity Ratio of 0.11 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -153.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.28% in the last quarter to 27.28.

Interest Coverage Ratio is -43.68, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 0.01% in the last quarter to 81.84.

Alto Neuroscience Inc. - Company Profile

What does Alto Neuroscience Inc. do?

Alto Neuroscience Inc. Management structure

Dr. Amit Etkin, M.D.,PhD

President, Chief Executive Officer and Chairman of the Board

Mr. Michael Conick Hanley, Jr

Chief Operating Officer

Mr. Nicholas Conrad Smith

Chief Business Officer, Chief Financial Officer and Principal Accounting Officer

Mr. Adam Savitz, M.D.,PhD

Chief Medical Officer

Alto Neuroscience Inc. Board of directors

Mr. Christopher Nixon Cox

Lead Independent Director

Ms. Gwill York

Independent Director

Mr. Andrew Dreyfus

Independent Director

Dr. Po Yu Chen, PhD

Independent Director

Dr. Husseini Manji, M.D.

Independent Director

Ms. Mahalakshmi Radhakrishnan, M.D.

Independent Director

Alto Neuroscience Inc. FAQ

How is Alto Neuroscience Inc. today?

Alto Neuroscience Inc. today is trading in the red, and is down by -0.43% at 2.31.

How has Alto Neuroscience Inc. performed historically?

Alto Neuroscience Inc. is currently trading down -0.43% on an intraday basis. In the past week the stock rose 11.06%. stock has been down -51.16% in the past quarter and fell -82.18% in the past year. You can view this in the overview section.